Boehringer Hit With New Sanctions In Pradaxa MDL

Law360, New York (March 13, 2014, 6:15 PM EDT) -- An Illinois federal judge ordered Boehringer Ingelheim International GmbH on Thursday to reimburse plaintiffs for the offices they rent for European depositions in the multidistrict litigation over the blood thinner Pradaxa, a discovery-related sanction on top of last year's nearly $1 million fine.

When U.S. District Judge David Herndon imposed sanctions against BII and U.S. unit Boehringer Ingelheim Pharmaceuticals Inc. in December, he instructed the companies to make European employees available for depositions in the U.S. That order, along with the $931,500 fine, was punishment for...
To view the full article, register now.